Network origin in Graham Johnson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Oricula Therapeutics LLC
 Oricula Therapeutics LLC BiotechnologyHealth Technology Oricula Therapeutics LLC develops medication to prevent hearing loss. Its products is ORC-13661, a medicine to preserve hearing during aminoglycoside therapy, has completed preclinical development and has been approved to move into early human testing for safety, tolerability and pharmacokinetics. The company was founded in 2013 and is headquartered in Seattle, WA.
1
| Private Company | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Graham Johnson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Essen BioScience, Inc.
 Essen BioScience, Inc. Medical SpecialtiesHealth Technology Essen Bioscience, Inc. specializes in developing and manufacturing instruments, software, reagents and consumables for real-time live-cell imaging and data analysis. Its cell imaging and electrophysiology products are used in academic and industrial laboratories. The company was founded by Kirk Schroeder and Brad Neagle in 1999 and is headquartered in Ann Arbor, MI. | Medical Specialties | Corporate Officer/Principal |
Statistics
International
| United States | 2 |
Sectoral
| Health Technology | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Vincent Groppi | 2 |
- Stock Market
- Insiders
- Graham Johnson
- Company connections
